Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?

被引：0
|
作者：
Brew, Bruce J. [1 ,2 ,3 ]
Clifford, David B. [4 ,5 ]
机构：
[1] Univ New South Wales & Notre Dame, St Vincents Hosp, Dept Neurol, Sydney, NSW, Australia
[2] Univ New South Wales & Notre Dame, St Vincents Hosp, Dept HIV Med, Sydney, NSW, Australia
[3] Univ New South Wales & Notre Dame, St Vincents Hosp, Peter Duncan Neurosci Unit, Sydney, NSW, Australia
[4] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA
[5] Washington Univ St Louis, Dept Neurol, Clin Neuropharmacol Neurol, Box 8111,660 South Euclid Ave, St Louis, MO 63110 USA
来源：
AIDS | 2023年 / 37卷 / 13期
关键词：
HUMAN-IMMUNODEFICIENCY-VIRUS;
D O I：
10.1097/QAD.0000000000003694
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2095 / 2096
页数：2
相关论文
共 50 条
  • [1] Progression of HIV-associated Neurocognitive Disorder in the Context of Combined Antiretroviral Therapy
    Loughan, A.
    Lanoye, A.
    Malkin, M.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2016, 31 (06) : 572 - 572
  • [2] Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda
    Sacktor, Ned
    Saylor, Deanna
    Nakigozi, Gertrude
    Nakasujja, Noeline
    Robertson, Kevin
    Grabowski, M. Kate
    Kisakye, Alice
    Batte, James
    Mayanja, Richard
    Anok, Aggrey
    Gray, Ronald H.
    Wawer, Maria J.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (02) : 216 - 223
  • [3] Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study
    Force, Gilles
    Ghout, Idir
    Ropers, Jacques
    Carcelain, Guislaine
    Marigot-Outtandy, Dhiba
    Hahn, Valerie
    Darchy, Natacha
    Defferriere, Helene
    Bouaziz-Amar, Elodie
    Carlier, Robert
    Dorgham, Karim
    Callebert, Jacques
    Peytavin, Gilles
    Delaugerre, Constance
    de Truchis, Pierre
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (03) : 743 - 752
  • [4] HIV-associated neurocognitive disorder
    Clifford, David B.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2017, 30 (01) : 117 - 122
  • [5] HIV-associated neurocognitive disorder
    Clifford, David B.
    Ances, Beau M.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (11): : 976 - 986
  • [6] HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies
    Etherton, Mark R.
    Lyons, Jennifer L.
    Ard, Kevin L.
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (06)
  • [7] HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies
    Mark R. Etherton
    Jennifer L. Lyons
    Kevin L. Ard
    [J]. Current Infectious Disease Reports, 2015, 17
  • [8] The Contribution of Antiretroviral Therapy to Neuronal Damage and Death as a Mediator of Cognitive Decline in HIV-Associated Neurocognitive Disorder
    Akay, Cagla
    Gannon, Patrick J.
    Odeleye, Akinleye
    Cooper, Michael D.
    White, Michael G.
    Ritson, Gillian
    Kolson, Dennis L.
    Jordan-Sciutto, Kelly L.
    [J]. JOURNAL OF NEUROVIROLOGY, 2010, 16 : 4 - 4
  • [9] Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
    Gates, Thomas M.
    Cysique, Lucette A.
    Siefried, Krista J.
    Chaganti, Joga
    Moffat, Kirsten J.
    Brew, Bruce J.
    [J]. AIDS, 2016, 30 (04) : 591 - 600
  • [10] HIV-associated mild neurocognitive disorder (MND)
    Tekin, Selma
    Degirmenci, Eylem
    Kutlu, Murat
    Degirmenci, Taner
    [J]. ACTA NEUROLOGICA BELGICA, 2020, 120 (02) : 433 - 435
12345